|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development expenses | |||||
| Administrative expenses | |||||
| Impairment of intangible assets | |||||
| Other income | |||||
| Net foreign exchange gains (losses) | |||||
| Operating loss | |||||
| Finance income | |||||
| Finance expense | |||||
| Loss before tax | |||||
| Income tax credit | |||||
| Loss for the year attributable to equity holders of the Company | |||||
| Basic loss per ordinary share | |||||
| Diluted loss per ordinary share |
Loading...
